Here are five observations:
1. The growing popularity of minimally invasive spine surgeries will boost the global market, as many of these procedures use medical polymers.
2. Unfavorable reimbursements, however, will serve as a detriment to market growth.
3. Providers are increasingly seeking biodegradable plastics in implants as they yield enhanced outcomes and performances compared to alternatives.
4. Biodegradable polymers avoid the possibility of refractures, sometimes occurring with the removal of a metal-based implant.
5. Key market vendors include Celanese, Covestro, Dow Chemical, Eastman Chemical and Evonik.
More articles on devices:
Medtronic, NuVasive, Life Spine & more: 14 device company notes
Medtronic, Smith & Nephew & more: 9 device company mergers, acquisitions and agreements
Global hip reconstruction devices to grow $126.6M per annum through 2022 — 6 observations
